| #75 |
Tamar R. Grossman |
Ionis Pharmaceuticals |
2 |
| #75 |
Benjamin F. Cravatt |
Scripps Research |
2 |
| #75 |
Mark H. Tuszynski |
University of California |
2 |
| #75 |
Thomas Becker |
Agena Bioscience |
2 |
| #75 |
Alper S. Akyurek |
Texas Instruments |
2 |
| #75 |
Lieven Verslegers |
Luxtera |
2 |
| #75 |
David Fogel |
Color Butler |
2 |
| #75 |
Matthew Grendal |
— |
2 |
| #75 |
Erman KOKEN |
Qualcomm |
2 |
| #75 |
Scott Peterson |
Seagen |
2 |
| #75 |
Michael J. Kelner |
University of California |
2 |
| #75 |
Alexander Aksenov |
University of California |
2 |
| #75 |
Isaac Kim |
AT&T |
2 |
| #75 |
Roberto Spreafico |
Synthetic Genomics |
2 |
| #75 |
Nikola Alic |
Ntwine |
2 |
| #75 |
Yusuf Yazici |
Samumed |
2 |
| #75 |
Devin M. Swanson |
Johnson & Johnson |
2 |
| #75 |
Russell Dahl |
Neurodon |
2 |
| #75 |
Yan Deng |
Qualcomm |
2 |
| #75 |
Tomas M. Mustelin |
Medimmune Limited |
2 |
| #75 |
Tony Reid |
Epicentrx |
2 |
| #75 |
Patrick Mercier |
University of California |
2 |
| #75 |
Scott Franklin |
Solazyme |
2 |
| #75 |
Noelia J. Kunzevitzky |
— |
2 |
| #75 |
Behnam Sedighi |
Qualcomm |
2 |
| #75 |
Peter J. Black |
Qualcomm |
2 |
| #75 |
Fabrice Pierre |
Vertex Pharmaceuticals Incorporated |
2 |
| #75 |
Carl Melcher |
Amenity Health |
2 |
| #129 |
Hongjie HU |
Huawei |
1 |
| #129 |
Clifford W. Colwell |
Scripps Health |
1 |
| #129 |
Erica Ollmann Saphire |
Scripps Research |
1 |
| #129 |
Linda Bradley |
Sanford Burnham Prebys Medical Discovery Institute |
1 |
| #129 |
Steven Samuel Gal |
Intercept |
1 |
| #129 |
Alan Glicklich |
Arena Pharmaceuticals |
1 |
| #129 |
Justin Robbins |
Organovo |
1 |
| #129 |
Bodhisattwa Prasad Majumder |
Walmart Apollo |
1 |
| #129 |
Joel Daniel ARIAS |
Avidity Biosciences |
1 |
| #129 |
Md Harunur Rashid |
Ambrx |
1 |
| #129 |
Saheed Imam |
Viridos |
1 |
| #129 |
Kathleen Kwok |
Viridos |
1 |
| #129 |
K. Barry Sharpless |
MIT |
1 |
| #129 |
Hoang Cong Minh LE |
Qualcomm |
1 |
| #129 |
Yimu Chen |
University of California |
1 |
| #129 |
Steve Howard |
Reva Medical |
1 |
| #129 |
Boubacar Kante |
University of California |
1 |
| #129 |
Babak BAHARI |
University of California |
1 |
| #129 |
Rajay Pandit |
Inhibrx |
1 |
| #129 |
Robert Eastlack |
Spine Innovation |
1 |
| #129 |
Zhi-Yong CHEN |
Cidara Therapeutics |
1 |
| #129 |
Jeffrey W. Smith |
Airnet Communications |
1 |